Tao Xie

发表

Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p

Zhe-Sheng Chen, Xian-lu Song, Shan-Chao Zhao, 2022, Molecular cancer.

The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy.

Zhe-Sheng Chen, Jing-Quan Wang, Xian-lu Song, 2021, Drug discovery today.

CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling

Xian-lu Song, Shan-Chao Zhao, D. Lv, 2022, Molecular Cancer.

SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer

Xian-lu Song, Shan-Chao Zhao, Zhaohua Xiao, 2021, Frontiers in Cell and Developmental Biology.

Suppressed epithelial-mesenchymal transition and cancer stem cell properties mediate the anti-cancer effects of ethyl pyruvate via regulation of the AKT/nuclear factor-κB pathway in prostate cancer cells

Xian-lu Song, Shan-Chao Zhao, D. Lv, 2018, Oncology letters.

Elevated plasma fibrinogen and the neutrophil-to-lymphocyte ratio as predictive risk factors for prostate cancer

Xian-lu Song, Shan-Chao Zhao, Feng, 2019 .

Osthole increases the radiosensitivity of hepatoma cells by inhibiting GSK-3β/AMPK/mTOR pathway-controlled glycolysis

Meilin Xie, J. Xue, Tao Xie, 2022, Naunyn-Schmiedeberg's Archives of Pharmacology.

NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8

Chong Wang, Yu-zhong Yu, Tao Xie, 2024, Advanced science.

Identification of a basement membrane gene signature for predicting prognosis and estimating the tumor immune microenvironment in prostate cancer

Tao Xie, D. Fu, Shan-Chao Zhao, 2024, Aging.

SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest.

Tao Wang, Chong Wang, Yu-zhong Yu, 2023, Cancer letters.